Oncocyte shareholders approve 1.25M share increase to equity plan

Insight Molecular Diagnostics Inc.

Stockholders approved Amended and Restated 2018 Equity Incentive Plan adding 1,250,000 shares, total pool now 2,300,000 shares.
Vote: 8,469,172 for, 110,188 against, 8,410 abstained; 64.21% of voting power represented at special meeting on Oct 11, 2024.
Amendments remove fungible share counting, eliminate share recycling restrictions, and remove one-year vesting minimum.
Plan authorizes delegation of award grants to executive officers under Board-established limits.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.